0 Σχόλια
0 Μοιράστηκε
120 Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Atopic Dermatitis Market Growth: Key Drivers and Industry TrendsThe Atopic Dermatitis Market growth is driven by the increasing prevalence of eczema and the growing need for long-term treatment solutions. The condition often requires continuous management, which is boosting demand for effective therapies. Patients are increasingly seeking treatments that provide quick relief and minimize side effects. The rising awareness about skincare and dermatological...0 Σχόλια 0 Μοιράστηκε 696 Views 0 Προεπισκόπηση
-
Atopic Dermatitis Market: How Are New Biologic Mechanisms Expanding AD Treatment Options?Novel biologic mechanisms for atopic dermatitis — tralokinumab (Adbry), lebrikizumab (Ebglyss), nemolizumab, and pipeline biologics targeting IL-13 specifically, IL-31 itch signaling, TSLP, and OX40L — represent the diversification of AD biologic mechanisms beyond the established IL-4/IL-13 dual blockade of dupilumab, with the Atopic Dermatitis Market reflecting biologic diversity...0 Σχόλια 0 Μοιράστηκε 875 Views 0 Προεπισκόπηση
-
Tralokinumab Market Report: Atopic Dermatitis Treatment Trends" According to the latest report published by Data Bridge Market Research, the Tralokinumab Market The global Tralokinumab market size was valued at USD 500.50 million in 2024 and is expected to reach USD 1,275.07 million by 2032, at a CAGR of 12.40% during the forecast period This Tralokinumab Market research report has been formed with a nice blend...0 Σχόλια 0 Μοιράστηκε 127 Views 0 Προεπισκόπηση